Healthcare and Life Sciences

Format: 2017-02-21
Format: 2017-02-21
February 20, 2017 | 90 Pages | SKU: IRTNTR12061

Overview of the global intraosseous infusion devices market

According to Technavio’s analysts, the global intraosseous infusion devices market is anticipated to grow at a steady rate and post a CAGR of close to 5% during the forecast period. The growing demand for intraosseous devices in emergency and military medical facilities will drive the growth prospects for the global intraosseous infusion devices market for the next four years. Some of the major factors responsible for the growing adoption of these devices is the increasing admission rates under the critical and emergency unit and the growing demand for critical and emergency care procedures. In medical care facilities, intraosseous infusion devices are widely used when there is a failure of or delay in standard peripheral and catheter-based intravenous infusion access. In military medical facilities, FAST1 Intraosseous infusion system by Pyng Medical is widely used for military emergency and personal combat, which is easy and simple to use.

In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. Some of the major factors responsible for the market’s growth in the region is the growing incidence of cardiac diseases, obesity, and emergency medical cases, increasing incidence of chronic disorders, the strong presence of leading vendors, and their extensive distribution networks in the region.

Competitive landscape and key vendors

The global intraosseous infusion devices market is highly competitive and diversified due to the presence of a large number of regional and international vendors across the globe. Also, the profit margins of vendors will widen with the growing


February 20, 2017 | 98 Pages | SKU: IRTNTR12058

Overview of the global biliary stents market

According to Technavio’s analyst, the global biliary stents market is anticipated to grow at a steady rate and post a CAGR of more than 4% during the forecast period. The growing preference for minimally invasive (MI) procedures will drive the growth prospects for the global biliary stents market until the end of 2021. The market is witnessing an increasing demand for MI procedures to treat biliary diseases because these procedures deliver superior results with minimal complications and are increasingly used to manage diseases such as gallbladder-related diseases, pancreas-related diseases, and liver-related diseases. For instance, stenosis is performed using non-vascular stents, which is the most commonly remedied condition through an MI procedure. Also, biliary stent intervention is an MI procedure that does not require open surgery but uses medical imaging technology to guide instruments inside the body. In addition, MI procedures to treat biliary diseases offer faster recovery, less pain, fewer post-surgery infections, reduced hospital stays, reduced incision marks, bleeding control, minimal complications, and heightened accuracy, involves low-risk complications, and provides benefits such as lesser cost and reduced hospital stay.

In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the major


February 20, 2017 | 103 Pages | SKU: IRTNTR12053

Overview of the global dental imaging market

Technavio’s market research analyst predicts the global dental imaging market to grow steadily at a CAGR of above 8% by 2021. One of the primary drivers for this market is the rising edentulous population coupled with the increasing demand for oral care. Factors such as age, periodontal diseases, dental caries, and other dental conditions are some of the main reasons for this rapid increase in the demand for dental imaging. Also, since oral health is linked to cardiovascular diseases, low birth weights in pregnancy, and transmission of flu, private and government organizations are taking initiatives to avoid such health problems. For instance, Centre for Disease Control and Prevention (CDC) has partnered with agencies such as the American Dental Association and the American Academy of Periodontology to improve surveillance of periodontal diseases in the US adult population. Consequently, such initiatives will create awareness among the population and increase the demand for global dental imaging market during the forecast period.

In terms of geographical regions, the Americas were the major revenue contributor to the market during 2016. The growing prevalence of oral diseases such as tooth decay, chronic bad breath, and periodontal diseases, and bleeding gums is the major factor for the dominance of the dental imaging market in the region. Also, the growing number of dental implant procedures and advances in dentomaxillofacial surgeries is driving the market in North America. Panoramic X-ray imaging equipment is required to conduct 3D imaging analysis. Restoration of dental implants, which can often be complex, can be simplified using X-ray imaging and


February 17, 2017 | 84 Pages | SKU: IRTNTR12027

Overview of the global epinephrine autoinjector market

Technavio’s market research analyst predicts the global epinephrine autoinjector market to grow steadily at a CAGR of around 15% by 2021. One of the primary drivers for this market is the rise in prevalence of allergies across demographics. The prevalence of allergies to food items, food additives, latex, and dust and the associated anaphylaxis has been increasing worldwide. The allergies are observed to be more rampant in industrially developed countries like the US and UK. These allergic conditions are effectively combated by the use of epinephrine. Epinephrine works immediately and helps reduce the symptoms of a life-threatening allergy if it reaches the blood stream immediately during such emergencies. The growing number of such allergy cases and the popularity of epinephrine autoinjector will contribute to the increase in market share of the global epinephrine autoinjector market during the forecast period.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market for the next few years. The market dominance of this region in the global market can be attributed to the higher availability of low-cost generic epinephrine autoinjectors in the US market. Moreover, the growing awareness regarding anaphylactic shocks will contribute further to the growth of the market share of epinephrine autoinjector in the coming years.

Competitive landscape and key vendors

The global epinephrine autoinjector market is highly consolidated and competitive due to the presence of few established vendors holding major parts of the market share. These vendors compete against each other based on factors such as regulatory approvals


February 17, 2017 | 82 Pages | SKU: IRTNTR12030

Overview of the venous thromboembolism (VTE) therapeutics market

According to the market research analysts at Technavio, the global venous thromboembolism (VTE) therapeutics market is anticipated to witness impressive growth and post a CAGR of close to 7% over the forecast period. With the increase in surgical procedures such as hip and knee replacements, the market for VTE therapeutics is anticipated to have a positive outlook over the coming years. Joint replacement surgeries often result in long periods of immobility, increasing chances of developing deep vein thrombosis due to reduced blood flow. Moreover, according to the Center for Disease Control and Prevention, several cases or percutaneous coronary interventions, stent grafts, and coronary artery bypass grafting are performed each year, leading to increasing chances of developing thromboembolic events. This is also expected to boost the adoption of VTE therapeutics over the coming four years.

Patient assistance programs for VTE therapeutics, particularly for anticoagulants is an important trend gaining significant traction in the market. The vendors in the market are providing co-pay assistance to patients who are purchasing the indicated medications for VTE, for instance, Daiichi Sankyo’s drug Savaysa has an assistance program to provide financial assistance to those consuming the drug. Similarly, BMS provides support to patients buying its drugs through the Bristol-Myers Squibb Patient Assistance Foundation. With such assistance programs offered by pharmaceutical companies, the majority of patients feel inclined toward purchasing branded therapies, which will, in turn, propel this market’s growth prospects during the predicted period.

Competitive landscape and


February 17, 2017 | 95 Pages | SKU: IRTNTR12032

Overview of the global anatomic pathology testing market

According to the Technavio’s analyst, the global anatomic pathology testing market is anticipated to grow at a steady rate and will post a CAGR of more than 8% during the forecast period. The increasing use and efficiency of biomarkers in the diagnosis of various disease will drive the growth prospects of the global anatomic pathology testing market until the end of 2021. It has been observed that biomarkers are increasingly used in various clinical studies in the areas of proteomics, genomics, transcriptomics, and metabolomics to evaluate pharmacological, physiological, and disease processes. At present, biomarkers are increasingly used for cancer diagnostics, and some of the common biomarkers used for cancer detection are keratins, vimentin, S100protein, CD45, CD3, CD20, CD30, TTF-1, CDX2, BRST-2, HMB-45, RCC, and HEPAR1. Consequently, the volume of biomarker analysis for various disease diagnosis processes will increase in the coming years, which will accelerate the rate of sales of tissue diagnostic products.

In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market for the next four year. One of the major factors responsible for the market’s growth in the region is the growing


Pages